1 | ABC transporters | 0.828467 | ![W3Schools](img/view_img.png) |
2 | Adherens junction | 0.000000 | ![W3Schools](img/view_img.png) |
3 | Adipocytokine signaling pathway | 0.553217 | ![W3Schools](img/view_img.png) |
4 | African trypanosomiasis | 0.125830 | ![W3Schools](img/view_img.png) |
5 | Alanine, aspartate and glutamate metabolism | 0.828467 | ![W3Schools](img/view_img.png) |
6 | Aldosterone-regulated sodium reabsorption | 0.140763 | ![W3Schools](img/view_img.png) |
7 | alpha-Linolenic acid metabolism | 0.157914 | ![W3Schools](img/view_img.png) |
8 | Alzheimer's disease | 0.533969 | ![W3Schools](img/view_img.png) |
9 | Amino acid metabolism_Unclassified | 0.896578 | ![W3Schools](img/view_img.png) |
10 | Amino acid related enzymes | 0.965442 | ![W3Schools](img/view_img.png) |
11 | Amino sugar and nucleotide sugar metabolism | 0.988477 | ![W3Schools](img/view_img.png) |
12 | Aminoacyl-tRNA biosynthesis | 1.000000 | ![W3Schools](img/view_img.png) |
13 | Aminobenzoate degradation | 0.442952 | ![W3Schools](img/view_img.png) |
14 | Amoebiasis | 0.478280 | ![W3Schools](img/view_img.png) |
15 | Amyotrophic lateral sclerosis (ALS) | 0.572790 | ![W3Schools](img/view_img.png) |
16 | Antigen processing and presentation | 0.942434 | ![W3Schools](img/view_img.png) |
17 | Apoptosis | 0.592678 | ![W3Schools](img/view_img.png) |
18 | Arachidonic acid metabolism | 0.717924 | ![W3Schools](img/view_img.png) |
19 | Arginine and proline metabolism | 0.633352 | ![W3Schools](img/view_img.png) |
20 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 0.000000 | ![W3Schools](img/view_img.png) |
21 | Ascorbate and aldarate metabolism | 0.166805 | ![W3Schools](img/view_img.png) |
22 | Atrazine degradation | 0.361311 | ![W3Schools](img/view_img.png) |
23 | Bacterial chemotaxis | 0.942434 | ![W3Schools](img/view_img.png) |
24 | Bacterial invasion of epithelial cells | 0.153399 | ![W3Schools](img/view_img.png) |
25 | Bacterial motility proteins | 0.783717 | ![W3Schools](img/view_img.png) |
26 | Bacterial secretion system | 0.409129 | ![W3Schools](img/view_img.png) |
27 | Bacterial toxins | 0.930107 | ![W3Schools](img/view_img.png) |
28 | Basal transcription factors | 0.303138 | ![W3Schools](img/view_img.png) |
29 | Base excision repair | 0.612870 | ![W3Schools](img/view_img.png) |
30 | Benzoate degradation | 0.515058 | ![W3Schools](img/view_img.png) |
31 | beta-Alanine metabolism | 0.478280 | ![W3Schools](img/view_img.png) |
32 | beta-Lactam resistance | 0.851056 | ![W3Schools](img/view_img.png) |
33 | Betalain biosynthesis | 0.364071 | ![W3Schools](img/view_img.png) |
34 | Bile secretion | 0.263740 | ![W3Schools](img/view_img.png) |
35 | Biosynthesis and biodegradation of secondary metabolites_Unclassified | 0.098558 | ![W3Schools](img/view_img.png) |
36 | Biosynthesis of 12-, 14- and 16-membered macrolides | 0.782161 | ![W3Schools](img/view_img.png) |
37 | Biosynthesis of ansamycins | 0.696413 | ![W3Schools](img/view_img.png) |
38 | Biosynthesis of siderophore group nonribosomal peptides | 0.828467 | ![W3Schools](img/view_img.png) |
39 | Biosynthesis of type II polyketide backbone | 0.316639 | ![W3Schools](img/view_img.png) |
40 | Biosynthesis of type II polyketide products | 0.976632 | ![W3Schools](img/view_img.png) |
41 | Biosynthesis of unsaturated fatty acids | 0.195671 | ![W3Schools](img/view_img.png) |
42 | Biosynthesis of vancomycin group antibiotics | 0.896578 | ![W3Schools](img/view_img.png) |
43 | Biotin metabolism | 0.965442 | ![W3Schools](img/view_img.png) |
44 | Bisphenol degradation | 0.633352 | ![W3Schools](img/view_img.png) |
45 | Bladder cancer | 0.425849 | ![W3Schools](img/view_img.png) |
46 | Butanoate metabolism | 0.496492 | ![W3Schools](img/view_img.png) |
47 | Butirosin and neomycin biosynthesis | 0.696413 | ![W3Schools](img/view_img.png) |
48 | C5-Branched dibasic acid metabolism | 0.896578 | ![W3Schools](img/view_img.png) |
49 | Caffeine metabolism | 0.166805 | ![W3Schools](img/view_img.png) |
50 | Calcium signaling pathway | 0.974398 | ![W3Schools](img/view_img.png) |
51 | CAM ligands | 0.000000 | ![W3Schools](img/view_img.png) |
52 | Caprolactam degradation | 0.227943 | ![W3Schools](img/view_img.png) |
53 | Carbohydrate digestion and absorption | 0.873766 | ![W3Schools](img/view_img.png) |
54 | Carbohydrate metabolism_Unclassified | 0.409129 | ![W3Schools](img/view_img.png) |
55 | Carbon fixation in photosynthetic organisms | 0.828467 | ![W3Schools](img/view_img.png) |
56 | Carbon fixation pathways in prokaryotes | 0.515058 | ![W3Schools](img/view_img.png) |
57 | Cardiac muscle contraction | 0.717924 | ![W3Schools](img/view_img.png) |
58 | Carotenoid biosynthesis | 0.216799 | ![W3Schools](img/view_img.png) |
59 | Cell cycle | 0.319645 | ![W3Schools](img/view_img.png) |
60 | Cell cycle - Caulobacter | 0.717924 | ![W3Schools](img/view_img.png) |
61 | Cell cycle - yeast | 0.000000 | ![W3Schools](img/view_img.png) |
62 | Cell division_Unclassified | 0.739656 | ![W3Schools](img/view_img.png) |
63 | Cell motility and secretion_Unclassified | 0.851056 | ![W3Schools](img/view_img.png) |
64 | Cellular antigens | 0.227943 | ![W3Schools](img/view_img.png) |
65 | Chagas disease (American trypanosomiasis) | 0.176057 | ![W3Schools](img/view_img.png) |
66 | Chaperones and folding catalysts | 0.696413 | ![W3Schools](img/view_img.png) |
67 | Chloroalkane and chloroalkene degradation | 0.331420 | ![W3Schools](img/view_img.png) |
68 | Chlorocyclohexane and chlorobenzene degradation | 0.206043 | ![W3Schools](img/view_img.png) |
69 | Cholinergic synapse | 0.000000 | ![W3Schools](img/view_img.png) |
70 | Chromosome | 0.988477 | ![W3Schools](img/view_img.png) |
71 | Chronic myeloid leukemia | 0.558882 | ![W3Schools](img/view_img.png) |
72 | Circadian rhythm - plant | 0.346165 | ![W3Schools](img/view_img.png) |
73 | Citrate cycle (TCA cycle) | 0.276470 | ![W3Schools](img/view_img.png) |
74 | Clavulanic acid biosynthesis | 1.000000 | ![W3Schools](img/view_img.png) |
75 | Colorectal cancer | 0.639935 | ![W3Schools](img/view_img.png) |
76 | Complement and coagulation cascades | 0.000000 | ![W3Schools](img/view_img.png) |
77 | Cyanoamino acid metabolism | 0.783717 | ![W3Schools](img/view_img.png) |
78 | Cysteine and methionine metabolism | 0.965442 | ![W3Schools](img/view_img.png) |
79 | Cytochrome P450 | 0.667494 | ![W3Schools](img/view_img.png) |
80 | Cytokine receptors | 0.000000 | ![W3Schools](img/view_img.png) |
81 | Cytokine-cytokine receptor interaction | 0.000000 | ![W3Schools](img/view_img.png) |
82 | Cytoskeleton proteins | 0.988477 | ![W3Schools](img/view_img.png) |
83 | Cytosolic DNA-sensing pathway | 0.000000 | ![W3Schools](img/view_img.png) |
84 | D-Alanine metabolism | 0.553217 | ![W3Schools](img/view_img.png) |
85 | D-Arginine and D-ornithine metabolism | 0.478280 | ![W3Schools](img/view_img.png) |
86 | D-Glutamine and D-glutamate metabolism | 0.806014 | ![W3Schools](img/view_img.png) |
87 | Dilated cardiomyopathy (DCM) | 0.000000 | ![W3Schools](img/view_img.png) |
88 | Dioxin degradation | 0.761592 | ![W3Schools](img/view_img.png) |
89 | DNA repair and recombination proteins | 0.965442 | ![W3Schools](img/view_img.png) |
90 | DNA replication | 0.896578 | ![W3Schools](img/view_img.png) |
91 | DNA replication proteins | 0.988477 | ![W3Schools](img/view_img.png) |
92 | Drug metabolism - cytochrome P450 | 0.185678 | ![W3Schools](img/view_img.png) |
93 | Drug metabolism - other enzymes | 0.873766 | ![W3Schools](img/view_img.png) |
94 | ECM-receptor interaction | 0.000000 | ![W3Schools](img/view_img.png) |
95 | Electron transfer carriers_Unclassified | 0.289602 | ![W3Schools](img/view_img.png) |
96 | Endocrine and other factor-regulated calcium reabsorption | 0.140763 | ![W3Schools](img/view_img.png) |
97 | Endocytosis | 0.104326 | ![W3Schools](img/view_img.png) |
98 | Energy metabolism_Unclassified | 1.000000 | ![W3Schools](img/view_img.png) |
99 | Epithelial cell signaling in Helicobacter pylori infection | 0.654113 | ![W3Schools](img/view_img.png) |
100 | ErbB signaling pathway | 0.000000 | ![W3Schools](img/view_img.png) |
101 | Ether lipid metabolism | 0.592678 | ![W3Schools](img/view_img.png) |
102 | Ethylbenzene degradation | 0.851056 | ![W3Schools](img/view_img.png) |
103 | Fat digestion and absorption | 0.000000 | ![W3Schools](img/view_img.png) |
104 | Fatty acid biosynthesis | 0.442952 | ![W3Schools](img/view_img.png) |
105 | Fatty acid elongation in mitochondria | 0.248149 | ![W3Schools](img/view_img.png) |
106 | Fatty acid metabolism | 0.263740 | ![W3Schools](img/view_img.png) |
107 | Fc epsilon RI signaling pathway | 0.000000 | ![W3Schools](img/view_img.png) |
108 | Fc gamma R-mediated phagocytosis | 0.104326 | ![W3Schools](img/view_img.png) |
109 | Flagellar assembly | 0.783717 | ![W3Schools](img/view_img.png) |
110 | Flavone and flavonol biosynthesis | 0.639935 | ![W3Schools](img/view_img.png) |
111 | Flavonoid biosynthesis | 0.919473 | ![W3Schools](img/view_img.png) |
112 | Fluorobenzoate degradation | 0.195671 | ![W3Schools](img/view_img.png) |
113 | Focal adhesion | 0.000000 | ![W3Schools](img/view_img.png) |
114 | Folate biosynthesis | 0.717924 | ![W3Schools](img/view_img.png) |
115 | Fructose and mannose metabolism | 0.988477 | ![W3Schools](img/view_img.png) |
116 | Function unknown_Unclassified | 0.442952 | ![W3Schools](img/view_img.png) |
117 | G protein-coupled receptors | 0.491590 | ![W3Schools](img/view_img.png) |
118 | Galactose metabolism | 0.942434 | ![W3Schools](img/view_img.png) |
119 | Gastric acid secretion | 0.140763 | ![W3Schools](img/view_img.png) |
120 | General function prediction only_Unclassified | 0.761592 | ![W3Schools](img/view_img.png) |
121 | Geraniol degradation | 0.118642 | ![W3Schools](img/view_img.png) |
122 | Germination_Unclassified | 0.629516 | ![W3Schools](img/view_img.png) |
123 | Glioma | 0.000000 | ![W3Schools](img/view_img.png) |
124 | Glutamatergic synapse | 0.496492 | ![W3Schools](img/view_img.png) |
125 | Glutathione metabolism | 0.496492 | ![W3Schools](img/view_img.png) |
126 | Glycan bindng proteins | 0.000000 | ![W3Schools](img/view_img.png) |
127 | Glycan biosynthesis and metabolism_Unclassified | 0.392796 | ![W3Schools](img/view_img.png) |
128 | Glycerolipid metabolism | 0.761592 | ![W3Schools](img/view_img.png) |
129 | Glycerophospholipid metabolism | 0.851056 | ![W3Schools](img/view_img.png) |
130 | Glycine, serine and threonine metabolism | 0.572790 | ![W3Schools](img/view_img.png) |
131 | Glycolysis / Gluconeogenesis | 0.696413 | ![W3Schools](img/view_img.png) |
132 | Glycosaminoglycan biosynthesis - chondroitin sulfate | 0.000000 | ![W3Schools](img/view_img.png) |
133 | Glycosaminoglycan degradation | 0.303138 | ![W3Schools](img/view_img.png) |
134 | Glycosphingolipid biosynthesis - ganglio series | 0.239479 | ![W3Schools](img/view_img.png) |
135 | Glycosphingolipid biosynthesis - globo series | 0.409129 | ![W3Schools](img/view_img.png) |
136 | Glycosphingolipid biosynthesis - lacto and neolacto series | 0.627925 | ![W3Schools](img/view_img.png) |
137 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis | 0.316639 | ![W3Schools](img/view_img.png) |
138 | Glycosyltransferases | 1.000000 | ![W3Schools](img/view_img.png) |
139 | Glyoxylate and dicarboxylate metabolism | 0.331420 | ![W3Schools](img/view_img.png) |
140 | GnRH signaling pathway | 0.104326 | ![W3Schools](img/view_img.png) |
141 | GTP-binding proteins | 0.000000 | ![W3Schools](img/view_img.png) |
142 | Hedgehog signaling pathway | 0.000000 | ![W3Schools](img/view_img.png) |
143 | Hematopoietic cell lineage | 0.443312 | ![W3Schools](img/view_img.png) |
144 | Hepatitis C | 0.319645 | ![W3Schools](img/view_img.png) |
145 | Histidine metabolism | 0.783717 | ![W3Schools](img/view_img.png) |
146 | Homologous recombination | 0.828467 | ![W3Schools](img/view_img.png) |
147 | Huntington's disease | 0.331420 | ![W3Schools](img/view_img.png) |
148 | Hypertrophic cardiomyopathy (HCM) | 0.247864 | ![W3Schools](img/view_img.png) |
149 | Indole alkaloid biosynthesis | 0.312549 | ![W3Schools](img/view_img.png) |
150 | Influenza A | 0.553217 | ![W3Schools](img/view_img.png) |
151 | Inorganic ion transport and metabolism_Unclassified | 0.331420 | ![W3Schools](img/view_img.png) |
152 | Inositol phosphate metabolism | 0.227943 | ![W3Schools](img/view_img.png) |
153 | Insulin signaling pathway | 0.717924 | ![W3Schools](img/view_img.png) |
154 | Ion channels | 0.806014 | ![W3Schools](img/view_img.png) |
155 | Isoflavonoid biosynthesis | 0.547004 | ![W3Schools](img/view_img.png) |
156 | Isoquinoline alkaloid biosynthesis | 0.739656 | ![W3Schools](img/view_img.png) |
157 | Leishmaniasis | 0.746337 | ![W3Schools](img/view_img.png) |
158 | Leukocyte transendothelial migration | 0.000000 | ![W3Schools](img/view_img.png) |
159 | Limonene and pinene degradation | 0.460431 | ![W3Schools](img/view_img.png) |
160 | Linoleic acid metabolism | 0.988477 | ![W3Schools](img/view_img.png) |
161 | Lipid biosynthesis proteins | 0.376856 | ![W3Schools](img/view_img.png) |
162 | Lipid metabolism_Unclassified | 0.851056 | ![W3Schools](img/view_img.png) |
163 | Lipoic acid metabolism | 0.092993 | ![W3Schools](img/view_img.png) |
164 | Lipopolysaccharide biosynthesis | 0.896578 | ![W3Schools](img/view_img.png) |
165 | Lipopolysaccharide biosynthesis proteins | 0.739656 | ![W3Schools](img/view_img.png) |
166 | Long-term depression | 0.000000 | ![W3Schools](img/view_img.png) |
167 | Long-term potentiation | 0.000000 | ![W3Schools](img/view_img.png) |
168 | Lysine biosynthesis | 0.873766 | ![W3Schools](img/view_img.png) |
169 | Lysine degradation | 0.361311 | ![W3Schools](img/view_img.png) |
170 | Lysosome | 0.239479 | ![W3Schools](img/view_img.png) |
171 | MAPK signaling pathway | 0.000000 | ![W3Schools](img/view_img.png) |
172 | MAPK signaling pathway - yeast | 0.761592 | ![W3Schools](img/view_img.png) |
173 | Measles | 0.319645 | ![W3Schools](img/view_img.png) |
174 | Meiosis - yeast | 0.303138 | ![W3Schools](img/view_img.png) |
175 | Melanogenesis | 0.561693 | ![W3Schools](img/view_img.png) |
176 | Membrane and intracellular structural molecules_Unclassified | 0.572790 | ![W3Schools](img/view_img.png) |
177 | Metabolism of cofactors and vitamins_Unclassified | 0.392796 | ![W3Schools](img/view_img.png) |
178 | Metabolism of xenobiotics by cytochrome P450 | 0.195671 | ![W3Schools](img/view_img.png) |
179 | Methane metabolism | 0.965442 | ![W3Schools](img/view_img.png) |
180 | Mineral absorption | 0.828467 | ![W3Schools](img/view_img.png) |
181 | Mismatch repair | 0.873766 | ![W3Schools](img/view_img.png) |
182 | mRNA surveillance pathway | 0.391965 | ![W3Schools](img/view_img.png) |
183 | mTOR signaling pathway | 0.319645 | ![W3Schools](img/view_img.png) |
184 | N-Glycan biosynthesis | 0.783717 | ![W3Schools](img/view_img.png) |
185 | Naphthalene degradation | 0.376856 | ![W3Schools](img/view_img.png) |
186 | Neuroactive ligand-receptor interaction | 0.000000 | ![W3Schools](img/view_img.png) |
187 | Neurotrophin signaling pathway | 0.000000 | ![W3Schools](img/view_img.png) |
188 | Nicotinate and nicotinamide metabolism | 0.988477 | ![W3Schools](img/view_img.png) |
189 | Nitrogen metabolism | 0.806014 | ![W3Schools](img/view_img.png) |
190 | Nitrotoluene degradation | 0.761592 | ![W3Schools](img/view_img.png) |
191 | NOD-like receptor signaling pathway | 0.988477 | ![W3Schools](img/view_img.png) |
192 | Non-homologous end-joining | 0.111773 | ![W3Schools](img/view_img.png) |
193 | Notch signaling pathway | 0.558882 | ![W3Schools](img/view_img.png) |
194 | Novobiocin biosynthesis | 0.828467 | ![W3Schools](img/view_img.png) |
195 | Nucleotide excision repair | 0.828467 | ![W3Schools](img/view_img.png) |
196 | Nucleotide metabolism_Unclassified | 0.906897 | ![W3Schools](img/view_img.png) |
197 | Olfactory transduction | 0.000000 | ![W3Schools](img/view_img.png) |
198 | One carbon pool by folate | 0.965442 | ![W3Schools](img/view_img.png) |
199 | Oocyte meiosis | 0.000000 | ![W3Schools](img/view_img.png) |
200 | Other glycan degradation | 0.376856 | ![W3Schools](img/view_img.png) |
201 | Other ion-coupled transporters_Unclassified | 0.919473 | ![W3Schools](img/view_img.png) |
202 | Other transporters_Unclassified | 0.783717 | ![W3Schools](img/view_img.png) |
203 | Other types of O-glycan biosynthesis | 0.000000 | ![W3Schools](img/view_img.png) |
204 | Others_Unclassified | 0.828467 | ![W3Schools](img/view_img.png) |
205 | Oxidative phosphorylation | 0.612870 | ![W3Schools](img/view_img.png) |
206 | p53 signaling pathway | 0.629460 | ![W3Schools](img/view_img.png) |
207 | Pancreatic cancer | 0.000000 | ![W3Schools](img/view_img.png) |
208 | Pancreatic secretion | 0.140763 | ![W3Schools](img/view_img.png) |
209 | Pantothenate and CoA biosynthesis | 0.896578 | ![W3Schools](img/view_img.png) |
210 | Parkinson's disease | 0.806014 | ![W3Schools](img/view_img.png) |
211 | Pathogenic Escherichia coli infection | 0.000000 | ![W3Schools](img/view_img.png) |
212 | Pathways in cancer | 0.515058 | ![W3Schools](img/view_img.png) |
213 | Penicillin and cephalosporin biosynthesis | 0.239479 | ![W3Schools](img/view_img.png) |
214 | Pentose and glucuronate interconversions | 0.496492 | ![W3Schools](img/view_img.png) |
215 | Pentose phosphate pathway | 0.896578 | ![W3Schools](img/view_img.png) |
216 | Peptidases | 0.942434 | ![W3Schools](img/view_img.png) |
217 | Peptidoglycan biosynthesis | 0.919473 | ![W3Schools](img/view_img.png) |
218 | Peroxisome | 0.515058 | ![W3Schools](img/view_img.png) |
219 | Pertussis | 0.279331 | ![W3Schools](img/view_img.png) |
220 | Phagosome | 0.273627 | ![W3Schools](img/view_img.png) |
221 | Phenylalanine metabolism | 0.289602 | ![W3Schools](img/view_img.png) |
222 | Phenylalanine, tyrosine and tryptophan biosynthesis | 0.783717 | ![W3Schools](img/view_img.png) |
223 | Phenylpropanoid biosynthesis | 0.553217 | ![W3Schools](img/view_img.png) |
224 | Phosphatidylinositol signaling system | 0.783717 | ![W3Schools](img/view_img.png) |
225 | Phosphonate and phosphinate metabolism | 0.376856 | ![W3Schools](img/view_img.png) |
226 | Phosphotransferase system (PTS) | 0.206043 | ![W3Schools](img/view_img.png) |
227 | Photosynthesis | 0.592678 | ![W3Schools](img/view_img.png) |
228 | Photosynthesis - antenna proteins | 0.410724 | ![W3Schools](img/view_img.png) |
229 | Photosynthesis proteins | 0.612870 | ![W3Schools](img/view_img.png) |
230 | Phototransduction | 0.000000 | ![W3Schools](img/view_img.png) |
231 | Phototransduction - fly | 0.000000 | ![W3Schools](img/view_img.png) |
232 | Plant-pathogen interaction | 0.988477 | ![W3Schools](img/view_img.png) |
233 | Polycyclic aromatic hydrocarbon degradation | 0.988477 | ![W3Schools](img/view_img.png) |
234 | Polyketide sugar unit biosynthesis | 0.988477 | ![W3Schools](img/view_img.png) |
235 | Pores ion channels_Unclassified | 0.496492 | ![W3Schools](img/view_img.png) |
236 | Porphyrin and chlorophyll metabolism | 0.425849 | ![W3Schools](img/view_img.png) |
237 | PPAR signaling pathway | 0.346165 | ![W3Schools](img/view_img.png) |
238 | Prenyltransferases | 0.675138 | ![W3Schools](img/view_img.png) |
239 | Primary bile acid biosynthesis | 0.239479 | ![W3Schools](img/view_img.png) |
240 | Primary immunodeficiency | 0.533969 | ![W3Schools](img/view_img.png) |
241 | Prion diseases | 0.675138 | ![W3Schools](img/view_img.png) |
242 | Progesterone-mediated oocyte maturation | 0.942434 | ![W3Schools](img/view_img.png) |
243 | Propanoate metabolism | 0.289602 | ![W3Schools](img/view_img.png) |
244 | Prostate cancer | 0.965442 | ![W3Schools](img/view_img.png) |
245 | Proteasome | 0.851056 | ![W3Schools](img/view_img.png) |
246 | Protein digestion and absorption | 0.111773 | ![W3Schools](img/view_img.png) |
247 | Protein export | 0.942434 | ![W3Schools](img/view_img.png) |
248 | Protein folding and associated processing_Unclassified | 0.572790 | ![W3Schools](img/view_img.png) |
249 | Protein kinases | 0.572790 | ![W3Schools](img/view_img.png) |
250 | Protein processing in endoplasmic reticulum | 0.553217 | ![W3Schools](img/view_img.png) |
251 | Proximal tubule bicarbonate reclamation | 0.216799 | ![W3Schools](img/view_img.png) |
252 | Purine metabolism | 0.988477 | ![W3Schools](img/view_img.png) |
253 | Pyrimidine metabolism | 0.783717 | ![W3Schools](img/view_img.png) |
254 | Pyruvate metabolism | 0.515058 | ![W3Schools](img/view_img.png) |
255 | Regulation of actin cytoskeleton | 0.000000 | ![W3Schools](img/view_img.png) |
256 | Renal cell carcinoma | 0.392796 | ![W3Schools](img/view_img.png) |
257 | Renin-angiotensin system | 0.285774 | ![W3Schools](img/view_img.png) |
258 | Replication, recombination and repair proteins_Unclassified | 0.717924 | ![W3Schools](img/view_img.png) |
259 | Restriction enzyme_Unclassified | 0.675138 | ![W3Schools](img/view_img.png) |
260 | Retinol metabolism | 0.166805 | ![W3Schools](img/view_img.png) |
261 | Rheumatoid arthritis | 0.000000 | ![W3Schools](img/view_img.png) |
262 | Riboflavin metabolism | 0.739656 | ![W3Schools](img/view_img.png) |
263 | Ribosome | 0.851056 | ![W3Schools](img/view_img.png) |
264 | Ribosome Biogenesis | 0.942434 | ![W3Schools](img/view_img.png) |
265 | Ribosome biogenesis in eukaryotes | 0.828467 | ![W3Schools](img/view_img.png) |
266 | RIG-I-like receptor signaling pathway | 0.675138 | ![W3Schools](img/view_img.png) |
267 | RNA degradation | 0.828467 | ![W3Schools](img/view_img.png) |
268 | RNA polymerase | 0.806014 | ![W3Schools](img/view_img.png) |
269 | RNA transport | 0.851056 | ![W3Schools](img/view_img.png) |
270 | Salivary secretion | 0.140763 | ![W3Schools](img/view_img.png) |
271 | Secondary bile acid biosynthesis | 0.572790 | ![W3Schools](img/view_img.png) |
272 | Secretion system | 0.533969 | ![W3Schools](img/view_img.png) |
273 | Selenocompound metabolism | 0.988477 | ![W3Schools](img/view_img.png) |
274 | Sesquiterpenoid biosynthesis | 0.000000 | ![W3Schools](img/view_img.png) |
275 | Shigellosis | 0.370264 | ![W3Schools](img/view_img.png) |
276 | Signal transduction mechanisms_Unclassified | 0.965442 | ![W3Schools](img/view_img.png) |
277 | Small cell lung cancer | 0.639935 | ![W3Schools](img/view_img.png) |
278 | Sphingolipid metabolism | 0.496492 | ![W3Schools](img/view_img.png) |
279 | Spliceosome | 0.000000 | ![W3Schools](img/view_img.png) |
280 | Sporulation_Unclassified | 0.851056 | ![W3Schools](img/view_img.png) |
281 | Staphylococcus aureus infection | 0.276470 | ![W3Schools](img/view_img.png) |
282 | Starch and sucrose metabolism | 0.919473 | ![W3Schools](img/view_img.png) |
283 | Steroid biosynthesis | 0.263740 | ![W3Schools](img/view_img.png) |
284 | Steroid hormone biosynthesis | 0.317077 | ![W3Schools](img/view_img.png) |
285 | Stilbenoid, diarylheptanoid and gingerol biosynthesis | 0.758853 | ![W3Schools](img/view_img.png) |
286 | Streptomycin biosynthesis | 0.553217 | ![W3Schools](img/view_img.png) |
287 | Styrene degradation | 0.696413 | ![W3Schools](img/view_img.png) |
288 | Sulfur metabolism | 0.675138 | ![W3Schools](img/view_img.png) |
289 | Sulfur relay system | 0.919473 | ![W3Schools](img/view_img.png) |
290 | Synthesis and degradation of ketone bodies | 0.496492 | ![W3Schools](img/view_img.png) |
291 | Systemic lupus erythematosus | 0.248123 | ![W3Schools](img/view_img.png) |
292 | Taurine and hypotaurine metabolism | 0.496492 | ![W3Schools](img/view_img.png) |
293 | Terpenoid backbone biosynthesis | 0.942434 | ![W3Schools](img/view_img.png) |
294 | Tetracycline biosynthesis | 0.851056 | ![W3Schools](img/view_img.png) |
295 | TGF-beta signaling pathway | 0.000000 | ![W3Schools](img/view_img.png) |
296 | Thiamine metabolism | 0.806014 | ![W3Schools](img/view_img.png) |
297 | Tight junction | 0.000000 | ![W3Schools](img/view_img.png) |
298 | Toluene degradation | 0.346165 | ![W3Schools](img/view_img.png) |
299 | Toxoplasmosis | 0.639935 | ![W3Schools](img/view_img.png) |
300 | Transcription factors | 0.828467 | ![W3Schools](img/view_img.png) |
301 | Transcription machinery | 0.675138 | ![W3Schools](img/view_img.png) |
302 | Transcription related proteins_Unclassified | 0.515058 | ![W3Schools](img/view_img.png) |
303 | Translation factors | 0.942434 | ![W3Schools](img/view_img.png) |
304 | Translation proteins_Unclassified | 0.965442 | ![W3Schools](img/view_img.png) |
305 | Transporters | 0.896578 | ![W3Schools](img/view_img.png) |
306 | Tropane, piperidine and pyridine alkaloid biosynthesis | 0.942434 | ![W3Schools](img/view_img.png) |
307 | Tryptophan metabolism | 0.251411 | ![W3Schools](img/view_img.png) |
308 | Tuberculosis | 0.592678 | ![W3Schools](img/view_img.png) |
309 | Two-component system | 0.553217 | ![W3Schools](img/view_img.png) |
310 | Type I diabetes mellitus | 0.942434 | ![W3Schools](img/view_img.png) |
311 | Type II diabetes mellitus | 0.965442 | ![W3Schools](img/view_img.png) |
312 | Tyrosine metabolism | 0.654113 | ![W3Schools](img/view_img.png) |
313 | Ubiquinone and other terpenoid-quinone biosynthesis | 0.176057 | ![W3Schools](img/view_img.png) |
314 | Ubiquitin system | 0.331420 | ![W3Schools](img/view_img.png) |
315 | Valine, leucine and isoleucine biosynthesis | 0.717924 | ![W3Schools](img/view_img.png) |
316 | Valine, leucine and isoleucine degradation | 0.361311 | ![W3Schools](img/view_img.png) |
317 | Various types of N-glycan biosynthesis | 0.860749 | ![W3Schools](img/view_img.png) |
318 | Vascular smooth muscle contraction | 0.000000 | ![W3Schools](img/view_img.png) |
319 | Vasopressin-regulated water reabsorption | 0.208968 | ![W3Schools](img/view_img.png) |
320 | VEGF signaling pathway | 0.746337 | ![W3Schools](img/view_img.png) |
321 | Vibrio cholerae infection | 0.278146 | ![W3Schools](img/view_img.png) |
322 | Vibrio cholerae pathogenic cycle | 0.460431 | ![W3Schools](img/view_img.png) |
323 | Viral myocarditis | 0.639935 | ![W3Schools](img/view_img.png) |
324 | Vitamin B6 metabolism | 0.633352 | ![W3Schools](img/view_img.png) |
325 | Wnt signaling pathway | 0.558882 | ![W3Schools](img/view_img.png) |
326 | Xylene degradation | 0.478280 | ![W3Schools](img/view_img.png) |
327 | Zeatin biosynthesis | 0.988477 | ![W3Schools](img/view_img.png) |